ISO 25539-1 PDF

Reference number. ISO (E). This is a preview of “ISO “. Click here to purchase the full version from the ANSI store. Buy I.S. EN ISO CARDIOVASCULAR IMPLANTS – ENDOVASCULAR DEVICES – PART 1: ENDOVASCULAR PROSTHESES. Buy AAMI ISO Cardiovascular Implants – Endovascular Devices – Part 1: Endovascular Prostheses from SAI Global.

Author: Kazizahn JoJocage
Country: Mauritius
Language: English (Spanish)
Genre: Photos
Published (Last): 19 February 2006
Pages: 19
PDF File Size: 5.50 Mb
ePub File Size: 1.32 Mb
ISBN: 694-7-73042-828-8
Downloads: 20196
Price: Free* [*Free Regsitration Required]
Uploader: Voodoojas

Life 2559-1 A standard is reviewed every 5 years 00 Preliminary. Guidance for the development of in vitro test methods is included in an informative annex to this document. Pharmacological aspects of drug eluting or drug coated endovascular prostheses are not addressed in this document. Although contra-lateral iliac artery occluders when used as an integral part of aorto-uni-iliac endovascular prosthesis are within the scope of this document, specific requirements and testing are not described for these devices.

My account Shoping cart 0 Help. This document can be helpful in identifying the appropriate evaluation of the endovascular prosthesis component of a valved conduit, but specific requirements and testing are not described for these devices.

BS EN ISO 25539-1:2009

uso Although uses of endovascular systems other than treatment of arterial aneurysms or stenoses e. Pharmacological aspects of drug eluting or drug coated endovascular prostheses are not addressed in this document. Du abonnerer allerede dette emne.

Some of the requirements are specific to endovascular treatment of arterial aneurysms or stenoses. This document can be considered as a supplement to ISOwhich specifies general requirements for the performance of non-active surgical implants.

FAQ What is standard Become a member? Check out our FAQs.

Dauerhaftigkeitsprüfung an endovaskulären Prothesen nach ISO

Vis ikke denne igen. Pharmacological aspects of drug eluting or drug coated endovascular prostheses are not addressed in this document. Document Number ISO Certified by ISO This document can be helpful in identifying the appropriate evaluation of the endovascular prosthesis component of a valved conduit, but specific requirements and testing are not described for these devices.

  ASTM C1362 PDF

This standard is identical to: Prices subject to change without notice. Cardiovascular implants – Endovascular devices – Part 1: Proof sent to secretariat or FDIS ballot initiated: This document can be considered as a supplement to ISOwhich specifies general requirements for the performance of non-active surgical implants. Similarly, specific prosthesis configurations e. This document can be considered as a supplement to ISOwhich specifies general requirements for the performance of non-active surgical implants.

Although contra-lateral iliac artery occluders when used as an integral part of aorto-uni-iliac endovascular prosthesis are within the scope of this document, specific requirements and testing are not described for these devices. Balloons used to achieve adequate apposition of the prosthesis with the vessel wall or overlapping components are within the scope of this document, even if they are not integral to the endovascular system. Similarly, specific prosthesis configurations e. This document can be considered as a supplement to ISOwhich specifies general requirements for the performance of non-active surgical implants.

Similarly, specific prosthesis configurations e. The valve component of valved conduits constructed with an endovascular prosthesis component and the combination of the valved component and the endovascular prosthesis component are excluded from the scope of this document.

Monday to Friday – Kontakt venligst Dansk Standard. The valve component of valved conduits constructed with an endovascular prosthesis component and the combination of the valved component and the endovascular prosthesis component are excluded from the scope of this document. The valve component of valved conduits constructed with an endovascular prosthesis component and the combination of the valved component and the endovascular prosthesis component are excluded from the scope of this document.

This document can be helpful in identifying the appropriate evaluation of the endovascular prosthesis component of a valved conduit, but specific requirements and testing are not described for these devices. Balloons used to achieve adequate apposition of the prosthesis with the vessel wall or overlapping components are within the scope of this document, even if they are not integral to the endovascular system. Guidance for the development of in vitro test methods is included in an informative annex to this document.

  ENQUETE CNISF 2010 PDF

Some of the requirements are specific to endovascular treatment of arterial aneurysms or stenoses. Pharmacological aspects of drug eluting or drug coated endovascular prostheses are not addressed in this document. Cardiovascular implants – Endovascular devices – Part 2: The valve component of valved conduits constructed with an endovascular prosthesis component and the combination of the valved component and the endovascular prosthesis component are excluded from the scope of this document.

Endovascular prostheses ISO Guidance for the development of in vitro test methods is included in an informative annex to this document. The requirements for, and the evaluation of, degradation and other time-dependant aspects of absorbable materials used in the construction of endovascular prostheses are not addressed in this document.

Vena cava filters ISO First Balkan IT Conference for business platform for standardization Some of the requirements are specific to endovascular treatment of arterial aneurysms or stenoses. Although contra-lateral iliac artery occluders when used as an integral part of aorto-uni-iliac endovascular prosthesis are within the scope of this document, specific requirements and testing are not described for these devices. The requirements for, and the evaluation of, degradation and other time-dependant aspects of absorbable materials used in the construction of endovascular prostheses are not addressed in this document.

Although contra-lateral iliac artery occluders when used as an integral part of aorto-uni-iliac endovascular prosthesis are within the scope of this document, specific requirements and testing are not described for these devices.

The requirements for, and the evaluation of, degradation and other time-dependant aspects of absorbable materials used in the construction of endovascular prostheses are not addressed in this document.

Author: admin